MKI67 and neoplasm: Among the proliferation/apoptosis-related biomarkers that were immunohistochemically assessed (Table S3), only Ki67 showed a significant mean difference (p = 0.0003) between the fast-growing (24%) versus slow-growing (11%) tumour subgroups.